Labat Africa Ltd · JSE:LAB
Labat Africa — Investor Presentation (July 2020)
25 slides from Labat Africa's investor presentation, July 2020
Slide 1: Healthcare Investor Presentation
HEALTHCARE C U LT I VAT I N G T H E F U T U R E I N V E STO R PRESENTATION TECHNOLOGY LOGISTICS HEALTHCARE LIMITED www.labat.co.za
Slide 2: Slide 2
Slide 3: Contents
The LABAT HEALTHCARE Investor Presentation 1 // 23 CONTENTS I N T R O D U CT I O N L A B AT H E A LT H C A R E 2 L A B AT H E A LT H C A R E CO M PA N Y ST R U CT U R E 4 L A B AT H E A LT H C A R E M A N AG E M E N T T E A M 6 L A B AT H E A LT H C A R E O P P O RT U N I TY L A N D S C A P E 8 L A
Slide 4: Introduction Labat Healthcare
The LABAT HEALTHCARE Investor Presentation 2 // 23 01 INTRODUC TION LABAT HEALTHCARE
Slide 5: Introduction
The LABAT HEALTHCARE Investor Presentation 3 // 23 LABAT HEALTHCARE INTRODUCTION — Our vision is to be the number one healthcare company in South Africa with a focus on medicinal Cannabis. To utilize current skills and build on new skills to deliver world class products. Execute product and process
Slide 6: Labat Healthcare Company Structure
The LABAT HEALTHCARE Investor Presentation 4 // 23 02 L A B AT H E A LT H C A R E COMPANY STRUCTURE
Slide 7: Company Structure
The LABAT HEALTHCARE Investor Presentation 5 // 23 LABAT HEALTHCARE COMPANY STRUCTURE C U LT I VAT I N G THE FUTURE HEALTHCARE Labat Labat Labat Labat CannAfrica Pharmaceuticals Botanicals Hemp Intellectual 70% Owned 100% 70% Processing Property Owned Owned 100% 100% Owned Owned — The best businesse
Slide 8: Labat Healthcare Management Team
The LABAT HEALTHCARE Investor Presentation 6 // 23 03 L A B AT H E A LT H C A R E MANAGEMENT TEAM
Slide 9: Management Team
The LABAT HEALTHCARE Investor Presentation 7 // 23 LABAT HEALTHCARE MANAGEMENT TEAM Michael Stringer Herschel Maarsdorp (CEO) (CEO CannAfrica) Mike worked 30 years in the API industry and the Herschel is an entrepreneur, with a primary degree in last five years as CEO. He was key in developing the t
Slide 10: Labat Healthcare Opportunity Landscape
04 The LABAT HEALTHCARE Investor Presentation 8 // 23 L A BAT H E A LT H C A R E OPPORTUNITY LANDSCAPE 263 Million Past year cannabis users globally $58bn The value of the medicinal in Europe by 2028 $479m Global hemp food sales by 2020 $4.58bn Global hemp market expansion in 2019
Slide 11: Opportunity Landscape
The LABAT HEALTHCARE Investor Presentation 9 // 23 LABAT HEALTHCARE OPPORTUNITY LANDSCAPE $7.1bn The value of the legal African cannabis market by 2023 94% $667m The number of Medicinal cannabis medicinal cannabis market value in users who reported South Africa by 2023 improvement in their medical c
Slide 12: Labat Healthcare Overview
The LABAT HEALTHCARE Investor Presentation 10 // 23 LABAT HEALTHCARE OVERVIEW Labat LABAT BOTANICALS PHARMACEUTICALS HEALTHCARE LABAT CANNAFRICA HEMP PROCESSING 05 L A B AT H E A LT H C A R E OVERVIEW
Slide 13: Labat Botanicals
The LABAT HEALTHCARE Investor Presentation 11 // 23 EXECUTIVE SUMMARY LABAT BOTANICALS Labat Botanicals will set up a fully Good Agricultural Practice (GAP) and Good Manufacturing Processes (GMP) facility in the high-altitude, landlocked country of Lesotho we intend on being a market leader in skill
Slide 14: Labat Pharmaceuticals
The LABAT HEALTHCARE Investor Presentation 12 // 23 EXECUTIVE SUMMARY LABAT PHARMACEUTICALS Labat Pharmaceuticals aim to be a leader in Cannabis based Active Pharmaceutical Ingredients (API) and finished form dosage for the Complementary medicines Market as well as the Pharmaceuticals market. The co
Slide 15: CannAfrica
The LABAT HEALTHCARE Investor Presentation 13 // 23 EXECUTIVE SUMMARY CANNAFRICA CannAfrica is a multi-faceted entity, active in the Cannabis Industry and was registered in the Republic of South Africa after the groundbreaking constitutional court ruling in September 2018. Through a strategic partne
Slide 16: Labat Hemp Processing
The LABAT HEALTHCARE Investor Presentation 14 // 23 EXECUTIVE SUMMARY LABAT HEMP PROCESSING Labat Hemp Processing plans to secure a Hemp Processing and decortication equipment which will be set up adjacent to Labat Pharmaceuticals in Isithebe in KwaZulu-Natal . The plant will house state of the art
Slide 17: Value Chain
The LABAT HEALTHCARE Investor Presentation 15 // 23 06 Labat LABAT HEALTHCARE VALUE CHAIN Labat Labat Botanicals Hemp Processing Pharmaceuticals CannAfrica – – – – Medical Grade Hemp Pharmaceutical Cannabis Retail High THC Processing and Grade Cannabis Sector Cannabis CBD Extraction Production Purif
Slide 18: Labat Botanicals Production
The LABAT HEALTHCARE Investor Presentation 16 // 23 Medical Grade Medical Grade Cannabis Cannabis Production Output (grams) (kilograms) 2020 1 687 500 1 687 Labat Botanicals 1 968 750 1 969 2021 4 820 000 4 320 Labat Botanicals 3 600 000 3 600 2022 8 861 250 8 861 Labat Botanicals 7 331 250 7 331 20
Slide 19: Labat Pharmaceuticals Production
The LABAT HEALTHCARE Investor Presentation 17 // 23 Production Output - Units Year 1 Year 2 Year 3 Year 4 Year 5 Canna Anti 27 150 38 950 43 350 46 950 50 550 Ageing Canna Balm 27 150 38 950 43 350 46 950 50 550 Diet Fuel 3 258 4 674 5 202 5 634 6 066 Infused Glycerin 24 435 35 055 39 015 42 255 45
Slide 20: CannAfrica Sales Sheet
The LABAT HEALTHCARE Investor Presentation 18 // 23 YEARLY SALES BY CANNAFRICA 353 147 327 997 302 847 272 108 189 672 UNITS Year 1 Year 2 Year 3 Year 4 Year 5 CannAfrica Sales Year 1 Year 2 Year 3 Year 4 Year 5 Units Sold 189 672 272 108 302 847 327 997 353 147 09 CANNAFRICA SALES SHEET
Slide 21: 5 Year Outlook Revenue
The LABAT HEALTHCARE Investor Presentation 19 // 23 Labat Labat Labat Hemp Year 1 Botanicals Pharmaceuticals Processing CannAfrica CONSOLIDATED CONDENSED INCOME STATEMENTS Sales 75 937 500 48 921 852 - 59 965 327 184 824 679 Cost of goods sold 25 161 611 21 738 996 - 38 841 852 85 742 460 Gross Prof
Slide 22: 5 Year Outlook Revenue
The LABAT HEALTHCARE Investor Presentation 20 // 23 Labat Labat Labat Hemp Year 3 Botanicals Pharmaceuticals Processing CannAfrica CONSOLIDATED CONDENSED INCOME STATEMENTS Sales 442 140 930 159 865 230 72 240 000 106 162 880 780 409 039 Cost of goods sold 60 957 292 95 159 775 29 308 000 75 042 030
Slide 23: 5 Year Outlook Balance Sheet
The LABAT HEALTHCARE Investor Presentation 21 // 23 YEAR 1 YEAR 2 YEAR 3 YEAR 4 YEAR 5 CONDENSED BALANCE SHEETS ASSETS Non-current Assets Property Plant & Equipment 79 784 973 64 057 293 104 618 840 66 682 940 28 747 040 Current Assets Inventory 190 672 1 096 956 2 101 037 2 130 077 2 161 388 Trade
Slide 24: Labat Healthcare Capital Expenditure Requirement
The LABAT HEALTHCARE Investor Presentation 22 // 23 4% 45% R110 808 949 32% Labat Botanicals Labat Pharmaceuticals CannAfrica BREAKDOWN OF CAPEX Labat Botanicals CannAfrica Building Costs for Greenhouse R26 609 500 Retail Roll-out at R500k a store R5 000 000 Processing and Laboratory Facilities R17
Slide 25: Contact
CONTACT 23 Kroton Avenue Tel: (011) 675 6841 Weltevreden Park, 1709 Fax: (011) 675 1019 Private Bag X09-248, Weltevreden Park, 1715 Website: www.labat.co.za E-mail: labatafrica@mwebbiz.co.za